Dermatitis, Atopic: all 1,443 studies
Page 2 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.
- A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic DermatitisNot yet recruitingNCT07184645Phase 3
- Novel Skin Barrier Product Versus Petrolatum for Skin Barrier DysfunctionRecruitingNCT07183423Not applicable
- A Phase III Clinical Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis.Enrolling by invitationNCT07180511Phase 3
- A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic DermatitisNot yet recruitingNCT07175233Phase 2
- A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic DermatitisNot yet recruitingNCT07173478Phase 3
- Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic DermatitisNot yet recruitingNCT07162896Phase 3
- Validation Of A Parent Administered Symptom Score For Unsettled Infants (Every Baby is UnIQue)Not yet recruitingNCT07121062
- A Study of Stapokibatrt in Children Subjects With Atopic DermatitisNot yet recruitingNCT07106372Phase 3
- Post-Marketing Clinical Follow-Up Trial to Evaluate the Performance and Safety of the Medical Device 047 TD Dermatitis Cream in Adults and Children With Atopic and Contact Dermatitis Symptoms Confirmed by Clinical ParametersRecruitingNCT07056569Not applicable
- Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic DermatitisNot yet recruitingNCT07054736Phase 2
- Microbiome and Atopy in MaliRecruitingNCT07051902
- Thera-Clean® Microbubbles System in Patients With Skin DiseasesEnrolling by invitationNCT07050810Early Phase 1
- Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic DermatitisRecruitingNCT07042126Phase 3
- A Study of Two Different Formulations of 611 in Healthy Adult Subjects in ChinaNot yet recruitingNCT07042113Phase 1
- A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic DermatitisRecruitingNCT07037901Phase 2
- A Clinical Study Evaluating the Application of La Roche-Posay's New B5 Multi-Effect Soothing and Repairing Cream on Individuals With Facial Atopic DermatitisRecruitingNCT07022288Not applicable
- SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)RecruitingNCT07021495
- A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic DermatitisRecruitingNCT07015762Phase 1
- Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 WeeksRecruitingNCT07014007Not applicable
- A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic DermatitisRecruitingNCT07003425Phase 2
- Sodium in the Skin and Atopic DermatitisRecruitingNCT06998446
- Efficacy of Topical Cannabidiol for EczemaEnrolling by invitationNCT06994520Phase 2
- Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & AdultsRecruitingNCT06988605
- Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and PsoriasisRecruitingNCT06982352Phase 1
- Study of Stapokibatrt in Children Subjects With Atopic DermatitisNot yet recruitingNCT06956196Phase 3
- Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic DermatitisRecruitingNCT06947993Phase 2
- Study of CM512 in Patients With Moderate-to-Severe Atopic DermatitisRecruitingNCT06947980Phase 2
- Frequency of Food Allergy Confirm by Oral Food Challenge Among Foods Avoidance in Atopic Dermatitis ChildrenEnrolling by invitationNCT06947252Not applicable
- A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis PatientsRecruitingNCT06946641Phase 1
- Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier FunctionRecruitingNCT06943469Not applicable
- A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic DermatitisRecruitingNCT06931990Phase 1/2
- Efficacy of Acupuncture in the Treatment of Moderate-to-severe Atopic DermatitisNot yet recruitingNCT06922565Not applicable
- Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.RecruitingNCT06899204
- A Phase Ⅲ Comparative Study of QL2108 to Dupixent®Not yet recruitingNCT06884891Phase 3
- Drug Survival of Target Therapies in Atopic DermatitisRecruitingNCT06882148
- Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic DermatitisRecruitingNCT06880276Phase 3
- Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.RecruitingNCT06855745Phase 2
- Herbal Ointment in Treating Atopic Dermatitis TopicallyRecruitingNCT06850311Phase 2/3
- A Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants with Moderate-to-Severe Atopic DermatitisRecruitingNCT06815380
- A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)RecruitingNCT06808477Phase 1
- A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe EczemaRecruitingNCT06807281Phase 3
- Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and PsoriasisRecruitingNCT06801821
- ICP-332 in Subjects With Moderate to Severe Atopic DermatitisRecruitingNCT06775860Phase 3
- A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic DermatitisNot yet recruitingNCT06767540Phase 3
- IB/IIa Study of MG-K10 in Adolescent Moderately Severe PatientsRecruitingNCT06765005Phase 1/2
- A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)Not yet recruitingNCT06756126Phase 2
- A Phase I Clinical Trial to Evaluate CU-10101 UnguentEnrolling by invitationNCT06744569Phase 1
- A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-UpRecruitingNCT06732414
- Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic DermatitisRecruitingNCT06636240Not applicable
- An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database AnalysisRecruitingNCT06627335
- Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin DiseasesRecruitingNCT06599411
- A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic DermatitisRecruitingNCT06587685Phase 3
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsRecruitingNCT06564389Phase 1
- Dietary Intervention on AtopyRecruitingNCT06547372Not applicable
- A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of LutikizumabRecruitingNCT06524635Phase 2
- Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)RecruitingNCT06504160Phase 1
- The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic DermatitisRecruitingNCT06488742Not applicable
- Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic DermatitisNot yet recruitingNCT06487000Phase 2
- Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD PatientsNot yet recruitingNCT06465732Phase 4
- Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic DermatitisEnrolling by invitationNCT06464133
- Clinical Study of Trilinolein Cream for Prevention of Relapse in Remission of Moderate-to-severe Atopic Dermatitis.Not yet recruitingNCT06463353Not applicable
- Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore IndividualsRecruitingNCT06454942Not applicable
- A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic EczemaRecruitingNCT06453512Not applicable
- Evaluation of Efficacy and Safety of Enhanced External Counter-pulsation on Patients With Atopic Dermatitis and Inflammatory Skin Disease Requiring Wet Wrap TherapyNot yet recruitingNCT06448702Not applicable
- Analytical Validation of Wrist-Based Assessment of Nocturnal Scratch in Atopic Dermatitis and PsoriasisRecruitingNCT06448689
- Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic DermatitisRecruitingNCT06397911Phase 2
- Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis PatientsNot yet recruitingNCT06397781Phase 4
- Sand Play - the Effect of Biodiversity Exposure on Atopic DermatitisRecruitingNCT06390696Not applicable
- A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic DermatitisRecruitingNCT06383468Phase 3
- Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive ModelsRecruitingNCT06366932Phase 4
- AI App for Management of Atopic DermatitisRecruitingNCT06362629Not applicable
- Allergy, Asthma, and Atopic Eczema in FinlandNot yet recruitingNCT06330974
- A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or VitiligoRecruitingNCT06319781
- National Register of Moderate and Severe Adult Atopic DermatitisRecruitingNCT06313333
- A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic DermatitisRecruitingNCT06311682Phase 3
- Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics ProjectRecruitingNCT06300697Not applicable
- Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control PopulationRecruitingNCT06259669
- Topical Treatment for Atopic DermatitisRecruitingNCT06244212Not applicable
- CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness RegistryRecruitingNCT06238765
- Phase III Study of GR1802 Injection in Patients With Atopic DermatitisNot yet recruitingNCT06216392Phase 3
- Involvement of Pollutants in Atopic Dermatitis and PsoriasisNot yet recruitingNCT06213688Not applicable
- Nutritional Study to Determine the Effect of Fish Oil on Atopic DermatitisRecruitingNCT06194045Not applicable
- A Study to Observe How Pediatric Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions Respond to Dupilumab TreatmentRecruitingNCT06192563
- Virtual Reality for Pain Management During Dupilumab InjectionRecruitingNCT06182436Not applicable
- A Study to Evaluate the Safety and Efficacy of GR2002 Injection in Patients With Atopic Dermatitis.Not yet recruitingNCT06175143Phase 1
- Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical TrialsNot yet recruitingNCT06174493
- A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic DermatitisEnrolling by invitationNCT06158490Phase 2
- Registry for Systemic Eczema TreatmentsRecruitingNCT06136767
- Cardamom and Topical Roseomonas in Atopic DermatitisRecruitingNCT06096857Phase 2
- A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic DermatitisRecruitingNCT06055361Phase 1
- Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic DermatitisRecruitingNCT06026891Phase 3
- The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic DermatitisRecruitingNCT06022874
- DUPIlumab Dose REDUCtion in Patients With Controlled Atopic EczemaRecruitingNCT06004986Phase 4
- Collection of Samples From Subjects With Various Skin Conditions and Healthy VolunteersRecruitingNCT05994976
- Comparison of LimpiAD Cream 2.5% Plus Versus Its Vehicle and and a Basic Emollient in Patients With Atopic DermatitisRecruitingNCT05984420Not applicable
- Comparison of LimpiAD Cream 2.5% Plus Versus Vehicle and an Emollient in Patients With Atopic DermatitisRecruitingNCT05971355Not applicable
- Induced Pluripotent Stem Cell Derived Exosomes for the Treatment of Atopic DermatitisRecruitingNCT05969717Early Phase 1
- Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECTRecruitingNCT05938478
- Determinants of Chronic Inflammatory Skin Disease TrajectoriesRecruitingNCT05928169
- Molecular Signatures of Cutaneous Dupilumab ResponseRecruitingNCT05858619Phase 4